Trial Design

INSIGHTS ON CLINICAL TRIAL DESIGN

The Pharmacy Advantage In Direct-To-Patient Clinical Supply
Understand state pharmacy regulations, prescription requirements, and operational considerations for shipping clinical supplies directly from pharmacies to patients' homes in decentralized trial models.
Rethinking Trial Access Through Trust-Driven Design And Local Collaboration
Locally embedded research models help sponsors reach underserved populations while reducing burden on patients and health systems alike.
Achieving A 2.67x Reduction In Study Build Time For An Innovative Neuromodulation Study
This study explores the potential of Focused Ultrasound Neuromodulation in deepening meditative states, and the platform that helps enhance the overall experience for researchers and participants alike.
Why Specialty Lab Samples Are So Vulnerable To Trial Execution Errors
Biomarkers and other specialty lab samples are among the most fragile parts of clinical trial execution, but what makes them so vulnerable to mishandling, and what are the effects?

Rethinking Patient Representation In Breast Cancer Trials For Better Outcomes
5/22/2026

Broad patient representation in breast cancer trials is critical, and inclusive trial design improves data relevance, accelerates enrollment, and supports global approval and access.
How To Reduce Eligibility Risk And Prevent Protocol Deviations
3/18/2026

Eliminate enrollment-based protocol deviations and align with the latest FDA guidance by implementing a centralized, technology-enabled eligibility review to safeguard trial integrity.
Solutions To The Challenges Of Oncology Trials
5/6/2025

This significant Phase III trial, one of the largest global studies in head and neck cancer, faced considerable challenges including enrollment delays and an intricate study design.
Analyzing The FDA's Approach To Diversity In Clinical Trials
1/31/2025

Learn how utilizing diverse data resources and collaborating with stakeholders enables sponsors to foster a culture of inclusivity, meet regulatory requirements and ultimately advance medical science.
How Humans And AI Collaborate To Improve Quality, Speed, And Agility In Study Build
6/22/2026

Learn how combining human expertise with AI can improve speed, consistency, and oversight while identifying issues earlier and supporting higher-quality clinical trial execution.

ecoScout For Meetings

Discover Scout's strategies for elevated, eco-friendly face-to-face and hybrid events. ecoScout for Meetings takes a comprehensive approach to minimizing carbon emissions and maintaining the highest standards of quality and service.
First In Human (FIH) Fact Sheet

Altasciences has decades of experience designing, conducting, and reporting on first-in-human (FIH) clinical trials. For small or large molecules, simple or complex trials, we have the expertise, purpose-built Phase 1 facilities, and seamless processes to deliver quality with speed and ease.
Your Top Partner For Ophthalmic Drug Development

As a leading partner in ocular therapy, Altasciences is at the forefront of ophthalmic drug development. Our integrated CRO/CDMO solutions can support your program from lead candidate selection to market. You will benefit from working with a single partner as your product advances through each phase of drug development—from prototype formulation through preclinical testing, to early phase clinical trials, and manufacturing. This could mean up to 40% in time savings.
Explore Medable Studio

Achieve unprecedented control over the study creation and deployment process with a no-code interface.
Ready To Reach Proof Of Concept Faster?

Proof-of-concept provides a critical bridge between Phase 1 and Phase 2 trials, making an experienced CRO partner vital to achieving optimal outcomes for early-phase clinical research.